Cite

HARVARD Citation

    Yang, W. et al. (2018). Clinical outcomes of imatinib dose escalation versus sunitinib in first-line imatinib-failure gastrointestinal stromal tumour. Scandinavian journal of gastroenterology. pp. 1328-1334. [Online]. 
  
Back to record